NCT00113165
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +7 more
- Locations
-
- GSK Investigational Site Anniston, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Northport, Alabama, United States
- GSK Investigational Site Tuscaloosa, Alabama, United States